Summary unavailable.

Questions

Question 1

Which class of antianxiety agents is generally considered more suitable for intermittent or short-term use?

View answer and explanation
Question 2

What is the primary mechanism of action for most antianxiety agents?

View answer and explanation
Question 3

According to the text, what is a significant potential outcome of the long-term use of benzodiazepines?

View answer and explanation
Question 4

In which patient population is the use of antianxiety agents contraindicated?

View answer and explanation
Question 5

For which specific class of antianxiety agents does the text mention precautions related to severe underlying pulmonary disease?

View answer and explanation
Question 6

What is the potential interaction effect of taking benzodiazepines with alcohol or antihistamines?

View answer and explanation
Question 7

What vital signs are crucial to monitor frequently during the intravenous administration of antianxiety agents?

View answer and explanation
Question 8

When transitioning a patient to buspirone from another antianxiety agent, what is the recommended procedure for the previous medication?

View answer and explanation
Question 9

Which of the following is NOT listed as a long-term antianxiety agent?

View answer and explanation
Question 10

What is a characteristic that antianxiety agents do NOT possess?

View answer and explanation
Question 11

Antianxiety agents are contraindicated for use in patients with uncontrolled severe pain and which other condition?

View answer and explanation
Question 12

What is the recommended course of action regarding the dosage of antianxiety agents for patients with hepatic dysfunction?

View answer and explanation
Question 13

Concurrent use of antianxiety agents with which of the following drug classes should be avoided?

View answer and explanation
Question 14

What nursing assessment is critical for monitoring the therapeutic effect and side effects of antianxiety therapy?

View answer and explanation
Question 15

Why is it important to restrict the amount of antianxiety medication available to a depressed or suicidal patient?

View answer and explanation
Question 16

What is the primary reason for gradually decreasing the dose of a previous antianxiety agent when switching to buspirone?

View answer and explanation
Question 17

What is the key evaluation criterion for the effectiveness of antianxiety agent therapy?

View answer and explanation
Question 18

Which condition is a contraindication for the use of antianxiety agents?

View answer and explanation
Question 19

Besides antidepressants and opioid analgesics, which other drug class is mentioned to cause additive CNS depression when used with benzodiazepines?

View answer and explanation
Question 20

Slurred speech is mentioned as an indicator of what aspect of a patient's response to antianxiety therapy?

View answer and explanation
Question 21

What type of anxiety disorder is specifically mentioned in the 'General Use' section for antianxiety agents?

View answer and explanation
Question 22

During which two life stages is the use of antianxiety agents to be avoided?

View answer and explanation
Question 23

In addition to patients with hepatic dysfunction and severe renal impairment, in which patient group should benzodiazepines be used cautiously?

View answer and explanation
Question 24

What is a potential nursing diagnosis related to the side effects of antianxiety agents?

View answer and explanation
Question 25

Which statement about the properties of buspirone when switching medications is true?

View answer and explanation
Question 26

Which medication is identified as being suitable for long-term management of anxiety?

View answer and explanation
Question 27

What is a potential risk associated with prolonged high-dose therapy of antianxiety agents?

View answer and explanation
Question 28

Antianxiety agent use is contraindicated in patients with hypersensitivity, pre-existing CNS depression, and which other condition?

View answer and explanation
Question 29

Ataxia is a clinical sign used to assess what in a patient taking antianxiety agents?

View answer and explanation
Question 30

The potential nursing diagnosis 'Deficient knowledge' for a patient on antianxiety agents is related to what?

View answer and explanation
Question 31

Which of the following is an example of an antianxiety agent suitable for long-term use?

View answer and explanation
Question 32

Besides being comatose and having uncontrolled severe pain, what is another contraindication for using antianxiety agents?

View answer and explanation
Question 33

When are patients taking antianxiety agents considered more sensitive to CNS depressant effects, possibly requiring a lower dose?

View answer and explanation
Question 34

What is the primary evaluation outcome for a patient who has been on antianxiety medication?

View answer and explanation
Question 35

What is the general action of most agents in the antianxiety class?

View answer and explanation
Question 36

Which condition is listed as a contraindication for antianxiety agent therapy?

View answer and explanation
Question 37

A patient with a history of previous drug addictions is prescribed an antianxiety agent. What is the recommended approach?

View answer and explanation
Question 38

Additive CNS depression may occur when benzodiazepines are combined with which of the following?

View answer and explanation
Question 39

What is the rationale for assessing a patient's level of sedation using indicators like dizziness?

View answer and explanation
Question 40

Which of these is NOT a contraindication for the use of antianxiety agents?

View answer and explanation
Question 41

What is a potential risk that necessitates restricting the amount of an antianxiety drug available to a patient with a history of addiction?

View answer and explanation
Question 42

Which of the following agents is NOT suitable for short-term anxiety management?

View answer and explanation
Question 43

What is the primary interaction concern when most antianxiety agents are considered for use with MAO inhibitors?

View answer and explanation
Question 44

Prolonged high-dose therapy with antianxiety agents may lead to which of the following?

View answer and explanation
Question 45

Which patient population is identified as potentially being more sensitive to the CNS depressant effects of antianxiety agents?

View answer and explanation
Question 46

What is the primary management strategy for a patient with a history of addiction being treated with an antianxiety agent?

View answer and explanation
Question 47

Which of the following describes the therapeutic properties of antianxiety agents?

View answer and explanation
Question 48

For a patient receiving IV antianxiety medication, how often should BP, pulse, and respiratory status be monitored?

View answer and explanation
Question 49

The text advises using antianxiety agents with caution in patients who are suicidal or have had previous drug addictions. What other precaution is mentioned?

View answer and explanation
Question 50

What is the primary reason for a potential nursing diagnosis of 'Risk for injury' in a patient taking antianxiety agents?

View answer and explanation

Other chapters

HOW TO USE DAVIS'S DRUG GUIDE FOR NURSESEVIDENCE-BASED PRACTICE AND PHARMACOTHERAPEUTICS: Implications for NursesPHARMACOGENOMICSMEDICATION ERRORS: Improving Practices and Patient SafetyDETECTING AND MANAGING ADVERSE DRUG REACTIONSOVERVIEW OF RISK EVALUATION AND MITIGATION SYSTEMS (REMS)SPECIAL DOSING CONSIDERATIONSTHE CYTOCHROME P450 SYSTEMEDUCATING PATIENTS ABOUT SAFE MEDICATION USEAnti-Alzheimer's agentsAntianemicsAntianginalsAntiarrhythmicsAntiasthmaticsAnticholinergicsAnticoagulantsAnticonvulsantsAntidepressantsAntidiabeticsAntidiarrhealsAntiemeticsAntifungalsAntihistaminesAntihypertensivesAnti-infectivesAntineoplasticsAntiparkinson agentsAntiplatelet agentsAntipsychoticsAntipyreticsAntirheumaticsAntiulcer agentsAntiviralsBeta blockersBone resorption inhibitorsBronchodilatorsCalcium channel blockersCentral nervous system stimulantsCorticosteroidsDiureticsHormonesImmunosuppressantsLaxativesLipid lowering agentsMinerals/electrolytes/pH modifiersNonopioid analgesicsNonsteroidal anti-inflammatory agentsOpioid analgesicsSedative/hypnoticsSkeletal muscle relaxantsThrombolyticsVaccines/immunizing agentsVitaminsDRUGS APPROVED IN CANADANATURAL/HERBAL PRODUCTSMEDICATION SAFETY TOOLSAppendix A. Recent Drug ApprovalsAppendix E. Administering Medications to ChildrenAppendix G. Pediatric Dosage CalculationsAppendix I. Controlled Substance SchedulesAppendix L. Insulins and Insulin TherapyAppendix M. Canadian and U.S. Pharmaceutical PracticesAppendix N. Routine Pediatric and Adult Immunizations